This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX USA Congress
Life Science Executive Partnering
Congress Sept 23-24, Forums Sept 22, 2026Hynes Convention Center, Boston, USA

Mark Cabato
Chief Business Officer at Immunis Inc
Speaker

Profile

Mark has more than 20 years of healthcare finance experience having spent the last 15 years at a large global financial institution where he was recently a director in the healthcare corporate and investment banking unit. He was responsible for large global pharmaceutical sector coverage and provided both financial solutions collaborating with multiple product groups across the globe as well as strategic advice primarily to U.S. and Japanese pharmaceutical companies and biotechs working closely with the global M&A team.

Mark brings strong relationships with a broad range of pharma and biotech executives, corporate development, and other industry leaders and is well respected for his thoughtful perspective and analytical skills. Mark also combines a deep strategic understanding of the biopharma industry and capital markets with breadth of experience in strategic planning, business development, and life science valuation. His versatility and collaborative mind-set will be important in forging new strategic growth opportunities and are a welcomed and valuable addition to the Immunis team.

Mark has a BS in Civil Engineering from Bucknell University, an MA in Communication Management from the University of Southern California and is a CFA Charterholder and member of the CFA Society of Los Angeles.

Agenda Sessions

  • Beyond the Exit: Should Product Launch Be Your Ultimate Goal?

    11:50am